Clinical Trial Update: Safety and Efficacy of tPBM for Epileptiform Activity in Autism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of transcranial photobiomodulation for epileptiform activity in autism has completed. The update indicates assessme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Epilepsy
• Neurodevelopmental Disorders
• Neurological Disorder

Drugs mentioned

• Transcranial photobiomodulation (tPBM)

Snippet

Sponsor: Richard Frye | Conditions: Autism Spectrum Disorder, EEG With Periodic Abnormalities | Phase 2 | Status: COMPLETED